VIJAYABSEVijaya Diagnostic Centre LtdHighNeutral
Announced Thu, 7 May · 19:09 IST

Please refer the attachment

Revenue Growth 20pctPat Growth 25pctEbitda Margin ExpansionResults RestatedExceptional ItemResults View source PDF

VIJAYA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+10.1%1-day move
₹1208.00
prior close
₹1269.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-2.4-2.7-2.5-2.9+10.1+6.0+7.0+6.0+11.3+8.0+3.4+8.1+10.1
Up moveDown movePending
AI summary

Vijaya Diagnostic Centre reported strong FY26 results with standalone revenue from operations of Rs. 76,542.88 lakhs, up 20.7% from Rs. 63,400.30 lakhs in FY25. Profit after tax grew 31.2% to Rs. 17,831.03 lakhs from Rs. 13,592.97 lakhs. EBITDA margin expanded to approximately 51% from 49% in the prior year, indicating improved operational efficiency. The board recommended a dividend of Rs. 2 per share (200%) for FY26. The company completed the amalgamation of subsidiary Medinova Diagnostic Services Limited during the year, with prior period figures restated. Statutory auditors issued an unmodified (clean) opinion on the financial results.

Likely market impact

The company delivered robust double-digit revenue and PAT growth with margin expansion, signaling operational strength. The clean audit opinion and maiden dividend recommendation are positive signals for shareholders.